Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom

Paul Benjamin Loughrey; John  Ayuk; Bilal Bashir; Claire E. Higham; Jan Hoong Ho; Philip J  Monaghan; Gwen Wark; Safwaan Adam

doi:10.1093/ejendo/lvaf034

Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom

Paul Benjamin Loughrey
, John Ayuk
, Bilal Bashir
, Claire E. Higham
, Jan Hoong Ho
, Philip J Monaghan
, Gwen Wark
, Safwaan Adam

Research output: Contribution to journal › Article › peer-review

52 Downloads (Pure)

Original language	English
Pages (from-to)	L7-L11
Journal	European Journal of Endocrinology
Volume	192
Issue number	3
DOIs	https://doi.org/10.1093/ejendo/lvaf034
Publication status	Published - 05 Mar 2025

Publications and Copyright Policy

This work is licensed under Queen’s Research Publications and Copyright Policy.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Growth hormone
Acromegaly
Endocrinology
Insulin-like growth factor 1
Laboratory assay
Gigantism
Pituitary

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism

Access to Document

10.1093/ejendo/lvaf034Licence: Unspecified

Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom
Copyright 2025 the authors. This is an accepted manuscript distributed under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
Accepted author manuscript, 431 KBLicence: CC BY

UK Society for Endocrinology Acromegaly Registry Steering Group (External organisation)
Loughrey, B. (Member)
2022 → …
Activity: Membership types › Membership of national or international committees and working groups

Cite this

Loughrey, P. B., Ayuk, J., Bashir, B., Higham, C. E., Ho, J. H., Monaghan, P. J., Wark, G., & Adam, S. (2025). Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom. European Journal of Endocrinology, 192(3), L7-L11. https://doi.org/10.1093/ejendo/lvaf034

@article{5549d457b7674896891e17fc92815f45,

title = "Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom",

keywords = "Growth hormone, Acromegaly, Endocrinology, Insulin-like growth factor 1, Laboratory assay, Gigantism, Pituitary",

author = "Loughrey, \{Paul Benjamin\} and John Ayuk and Bilal Bashir and Higham, \{Claire E.\} and Ho, \{Jan Hoong\} and Monaghan, \{Philip J\} and Gwen Wark and Safwaan Adam",

year = "2025",

month = mar,

day = "5",

doi = "10.1093/ejendo/lvaf034",

language = "English",

volume = "192",

pages = "L7--L11",

journal = "European Journal of Endocrinology",

issn = "0804-4643",

publisher = "Oxford University Press",

number = "3",

}

Loughrey, PB, Ayuk, J, Bashir, B, Higham, CE, Ho, JH, Monaghan, PJ, Wark, G & Adam, S 2025, 'Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom', European Journal of Endocrinology, vol. 192, no. 3, pp. L7-L11. https://doi.org/10.1093/ejendo/lvaf034

Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom. / Loughrey, Paul Benjamin; Ayuk, John ; Bashir, Bilal et al.
In: European Journal of Endocrinology, Vol. 192, No. 3, 05.03.2025, p. L7-L11.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom

AU - Loughrey, Paul Benjamin

AU - Ayuk, John

AU - Bashir, Bilal

AU - Higham, Claire E.

AU - Ho, Jan Hoong

AU - Monaghan, Philip J

AU - Wark, Gwen

AU - Adam, Safwaan

PY - 2025/3/5

Y1 - 2025/3/5

KW - Growth hormone

KW - Acromegaly

KW - Endocrinology

KW - Insulin-like growth factor 1

KW - Laboratory assay

KW - Gigantism

KW - Pituitary

U2 - 10.1093/ejendo/lvaf034

DO - 10.1093/ejendo/lvaf034

M3 - Article

SN - 0804-4643

VL - 192

SP - L7-L11

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

IS - 3

ER -

Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom

Publications and Copyright Policy

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Activities

UK Society for Endocrinology Acromegaly Registry Steering Group (External organisation)

Cite this